3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Wilms Tumor
2
Urothelial Cancer
2
Rhabdoid Tumor
2
Neuroectodermal Tumors, Primitive, Peripheral
2
Neuroblastoma
2
Medulloblastoma
2
Lymphoma, Non-Hodgkin
2
Histiocytosis, Langerhans-Cell
2
Hepatoblastoma
2
Glioma
2
Ependymoma
2
Central Nervous System Neoplasms
2
Xanthogranuloma, Juvenile
1
Urinary Bladder Neoplasms
1
Sarcoma, Ewing
1
Sarcoma
1
Rhabdomyosarcoma
1
Prostatic Neoplasms
1
Osteosarcoma
1
Non-Muscle Invasive Bladder Neoplasms
1
Multiple Myeloma
1
Malignant Solid Neoplasm
1
Lymphoma
1
Histiocytic Sarcoma
1
Familial ependymoma
1
Carcinoma, Transitional Cell
1
Breast Neoplasms
1
Advanced Solid Tumor
1
Interventions
pemigatinib
5
derazantinib
2
pembrolizumab
1
brivanib
1
atezolizumab
1
Irinotecan
1
INCB 54828-101
1
Gemcitabine
1
Carboplatin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Acrocephalosyndactylia
×
erdafitinib
×
Clear all
No trials found.